Two experimental cancer drugs, one for ovarian cancer and one for a form of breast cancer, received Fast Track designation from the U.S. Food and Drug Administration, which will speed up the regulatory process for these medications.
https://www.pharmalive.com/wp-content/uploads/2021/08/Two-More-Cancer-Drug-Candidates-Hit-the-Fast-Track-BioSpace-8-16-21.jpeg350625Andrew Humphreyshttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAndrew Humphreys2021-08-16 11:03:412021-08-16 11:09:05Two Cancer Drug Candidates Hit the Fast Track